Baxter Bros Inc. grew its position in Corteva, Inc. (NYSE:CTVA – Free Report) by 1.6% in the 4th quarter, HoldingsChannel.com reports. The firm owned 15,012 shares of the company’s stock after purchasing an additional 236 shares during the period. Baxter Bros Inc.’s holdings in Corteva were worth $855,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in CTVA. Flagship Wealth Advisors LLC purchased a new stake in Corteva in the 4th quarter valued at about $25,000. Noble Wealth Management PBC purchased a new stake in shares of Corteva during the fourth quarter valued at approximately $26,000. Hager Investment Management Services LLC bought a new stake in Corteva during the fourth quarter worth $27,000. Golden State Wealth Management LLC purchased a new position in Corteva in the fourth quarter worth $32,000. Finally, Centricity Wealth Management LLC bought a new position in Corteva in the 4th quarter valued at $34,000. 81.54% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently commented on CTVA shares. Royal Bank of Canada lifted their target price on Corteva from $72.00 to $73.00 and gave the stock an “outperform” rating in a research note on Friday, February 7th. Oppenheimer increased their target price on shares of Corteva from $70.00 to $72.00 and gave the company an “outperform” rating in a research report on Friday, February 7th. Citigroup lifted their price target on shares of Corteva from $69.00 to $74.00 and gave the stock a “buy” rating in a report on Wednesday, January 29th. Barclays increased their price objective on Corteva from $62.00 to $64.00 and gave the company an “equal weight” rating in a report on Tuesday, January 21st. Finally, Bank of America upped their price target on Corteva from $69.00 to $73.00 and gave the company a “buy” rating in a research report on Tuesday, February 11th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $68.00.
Corteva Trading Up 0.7 %
Corteva stock opened at $62.12 on Tuesday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. Corteva, Inc. has a fifty-two week low of $50.01 and a fifty-two week high of $66.24. The stock has a market cap of $42.59 billion, a P/E ratio of 48.16, a PEG ratio of 1.68 and a beta of 0.79. The firm’s fifty day moving average price is $62.48 and its 200-day moving average price is $59.95.
Corteva (NYSE:CTVA – Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. Equities research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.
Corteva Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Monday, March 3rd were paid a $0.17 dividend. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a yield of 1.09%. Corteva’s dividend payout ratio is presently 52.71%.
Insider Transactions at Corteva
In other Corteva news, insider Brian Titus sold 26,560 shares of Corteva stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the completion of the sale, the insider now owns 11,347 shares of the company’s stock, valued at $723,257.78. The trade was a 70.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.14% of the company’s stock.
About Corteva
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
See Also
- Five stocks we like better than Corteva
- High Flyers: 3 Natural Gas Stocks for March 2022
- Can SoundHound AI Double? What the Fundamentals and Deals Reveal
- What Is WallStreetBets and What Stocks Are They Targeting?
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Most Volatile Stocks, What Investors Need to Know
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.